Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-02-20 @ 6:42 PM
Study NCT ID:
NCT00511992
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2007-08-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
Sponsor:
University of Oklahoma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
2015-08-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-03
First Submit QC Date:
None
Study First Post Date:
2007-08-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-14
Results First Submit QC Date:
None
Results First Post Date:
2017-07-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-02
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL